Skip to content

Clinical trials

Phase 3 Rectal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rectal Neoplasms Phase: Phase 3 Country / region: United States Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20015
20036
20041
20054
20067
20074
20083
20091
20103
20112
20161
20202
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Terminated13
Unknown status6
Active, not recruiting4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology10
National Cancer Institute (NCI)7
Amgen2
M.D. Anderson Cancer Center2
Memorial Sloan Kettering Cancer Center2
NSABP Foundation Inc2
Novartis2
Pfizer2
SWOG Cancer Research Network2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rectal Neoplasms59
Colonic Neoplasms49
Colorectal Neoplasms39
Neoplasm Metastasis7
Breast Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Neoplasms4
Breast Neoplasms, Male3
Lung Neoplasms3
Prostatic Neoplasms3

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.